Main Menu

DEA’s Hypocritical Marijuana Decision Ignores The Evidence

DEA’s Hypocritical Marijuana Decision Ignores The Evidence

Emily Willingham | AUG 13, 2016

Do you know where caffeine comes from? What about acetylsalicylic acid, otherwise known as aspirin? How about digitalis? If you said “plants,” you get a gold star. Many plants make caffeine, the active ingredient in aspirin derives from willow bark, and digitalis, along with its cousin digoxin, are both used for heart conditions and come from foxglove.

These plants obviously had much to offer in terms of clinically effective therapeutics. Like any medical intervention, each one also has its side effects. Yet none of these side effects—which range from gastric bleeding to death—has led to these plants being classified as a Schedule I drug by the U.S. Drug Enforcement Administration (DEA). And all of themare approved by the U.S. Food and Drug Administration (FDA), sometimes in combination with each other. You can even grow the plants that make them in your yard, legally.

DEA’s Hypocritical Marijuana Decision Ignores The Evidence






Comments are Closed